X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (19) 19
humans (14) 14
female (13) 13
male (12) 12
aged (9) 9
middle aged (9) 9
adult (7) 7
expression (5) 5
adherence (4) 4
experiment (4) 4
particle physics (4) 4
united states (4) 4
abridged index medicus (3) 3
aged, 80 and over (3) 3
air pollution (3) 3
antirheumatic agents - therapeutic use (3) 3
arthritis, rheumatoid - drug therapy (3) 3
article (3) 3
autoimmune diseases (3) 3
discontinuation (3) 3
high energy physics - experiment (3) 3
impact (3) 3
internal medicine (3) 3
oncology (3) 3
particulate matter (3) 3
persistence (3) 3
physics (3) 3
physics - high energy physics - experiment (3) 3
rheumatoid arthritis (3) 3
rheumatoid factor (3) 3
toxicology (3) 3
treatment outcome (3) 3
united-states (3) 3
7000 gev-cms8000 gev-cms (2) 2
adolescent (2) 2
african-american (2) 2
air-pollution (2) 2
animals (2) 2
antibodies, monoclonal, murine-derived - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
antirheumatic agents - economics (2) 2
athletes (2) 2
autism (2) 2
autoimmunity (2) 2
biologics (2) 2
bosons (2) 2
brain (2) 2
broken symmetries (2) 2
cern lab (2) 2
cern lhc coll (2) 2
cms (2) 2
colliders (2) 2
corpus callosum (2) 2
corpus-callosum (2) 2
costs (2) 2
cyclophosphamide - therapeutic use (2) 2
decision-making (2) 2
development and progression (2) 2
developmental exposure (2) 2
diabetes (2) 2
diabetes mellitus (2) 2
disease-activity (2) 2
doxorubicin - therapeutic use (2) 2
drug use (2) 2
drugs (2) 2
etanercept (2) 2
ethnic-differences (2) 2
experimental results (2) 2
gene amplification (2) 2
health care sciences & services (2) 2
health policy & services (2) 2
hematology (2) 2
higgs bosons (2) 2
high energy physics (2) 2
immunochemotherapy (2) 2
immunologic factors - therapeutic use (2) 2
immunology (2) 2
infliximab (2) 2
insurance claim review (2) 2
lymphoma, b-cell - genetics (2) 2
medical colleges (2) 2
medication adherence - statistics & numerical data (2) 2
mice (2) 2
model higgs-boson (2) 2
multiple-sclerosis (2) 2
myc (2) 2
myelin (2) 2
osteoarthritis, knee - ethnology (2) 2
osteoarthritis, knee - surgery (2) 2
pharmaceutical industry (2) 2
pharmacology & pharmacy (2) 2
phenomenology (2) 2
physics of elementary particles and fields (2) 2
pp collisions (2) 2
prednisone - therapeutic use (2) 2
research (2) 2
retrospective studies (2) 2
rheumatoid-arthritis (2) 2
rheumatology (2) 2
rna-seq (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Health Services Research, ISSN 0017-9124, 08/2018, Volume 53, Issue 4, pp. 2735 - 2757
ObjectiveTo examine the impact of cost-sharing increases on continuity of specialty drug use in Medicare beneficiaries with multiple sclerosis (MS) or... 
Medicare | observational data/quasi‐experiments | chronic illness | pharmaceuticals: prescribing/use/costs | observational data/quasi-experiments | RHEUMATOID-ARTHRITIS | costs | use | PERSISTENCE | pharmaceuticals: prescribing | observational data | ADHERENCE | DISCONTINUATION | quasi-experiments | DISEASE-ACTIVITY | DAMAGE PROGRESSION | MEDICATION USE | MULTIPLE-SCLEROSIS | BIOLOGIC THERAPIES | HEALTH CARE SCIENCES & SERVICES | HEALTH POLICY & SERVICES | REMISSION | Medication Adherence - statistics & numerical data | Fees, Pharmaceutical - statistics & numerical data | United States | Humans | Immunosuppressive Agents - therapeutic use | Insurance Claim Review | Middle Aged | Male | Models, Statistical | Arthritis, Rheumatoid - drug therapy | Aged, 80 and over | Adult | Antirheumatic Agents - economics | Female | Aged | Cost Sharing - statistics & numerical data | Immunosuppressive Agents - economics | Antirheumatic Agents - therapeutic use | Medicare Part D - statistics & numerical data | Multiple Sclerosis - drug therapy | Poverty - statistics & numerical data | Drugs | Market share | Economic aspects | Prices and rates | Forecasts and trends | Pharmaceutical industry | Medical care, Cost of | Rheumatoid factor | Multiple sclerosis | Chronic diseases | Antiarthritic agents | Arthritis | Comparative analysis | Health care | Drug abuse | Data acquisition | Income | Drug development | Disease control | Sclerosis | Studies | Government programs | Rheumatoid arthritis | Data collection | Subsidies | Interruptions | Extraction | Continuity | Beneficiaries | Drug use | Subsidies (financial) | Index Medicus | quasi‐experiments | Health Insurance Coverage, Cost and Outcomes
Journal Article
British Journal of Haematology, ISSN 0007-1048, 11/2016, Volume 175, Issue 4, pp. 631 - 640
Rearrangement of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma ( DLBCL ) and B cell lymphoma unclassifiable ( BCLU ),... 
diffuse large B cell lymphoma | fluorescence | in situ | MYC | B cell lymphoma unclassifiable | hybridization | chemotherapy | fluorescence in situ hybridization | SURVIVAL | TRANSLOCATION | IMMUNOCHEMOTHERAPY | R-CHOP | CLASSIFICATION | TRANSPLANTATION | IMPACT | fluorescence insitu hybridization | BURKITT-LYMPHOMA | FEATURES INTERMEDIATE | HEMATOLOGY | EXPRESSION | Doxorubicin - therapeutic use | Prognosis | Humans | Lymphoma, B-Cell - diagnosis | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Genes, myc | Lymphoma, B-Cell - genetics | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Adult | Female | Lymphoma, B-Cell - drug therapy | Lymphoma, B-Cell - mortality | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Proportional Hazards Models | Treatment Outcome | Lymphoma, Large B-Cell, Diffuse - mortality | Lymphoma, Large B-Cell, Diffuse - diagnosis | Gene Amplification | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Bone Marrow - pathology | Gene Rearrangement | Vincristine - therapeutic use | Biomarkers | Vincristine - adverse effects | Aged | Neoplasm Staging | Antibodies, Monoclonal, Murine-Derived - adverse effects | Lymphoma, Large B-Cell, Diffuse - genetics | Doxorubicin - adverse effects | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Lymphomas | Index Medicus | Gene amplification | B cell lymphoma | CHEMOTHERAPY | Gene rearrangement
Journal Article
Journal of immunology (Baltimore, Md. : 1950), ISSN 0022-1767, 2/2018, Volume 200, Issue 3, pp. 909 - 914
Regulatory T cells utilize a distinct TCR repertoire and are more self-reactive compared to conventional T cells. However, the extent to which TCR affinity... 
type 1 diabetes | T cell receptor | autoimmunity | regulatory T cell
Journal Article
by Chatrchyan, S and Khachatryan, V and Sirunyan, A.M and Tumasyan, A and Adam, N and Adam, W and Aguilo, E and Bergauer, T and Dragicevic, M and Erö, J and Fabjan, C and Friedl, M and Frühwirth, R and Ghete, V.M and Hammer, J and Hoch, M and Hörmann, N and Hrubec, J and Jeitler, M and Kiesenhofer, W and Knünz, V and Krammer, M and Krätschmer, I and Liko, D and Majerotto, W and Mikulec, I and Pernicka, M and Rahbaran, B and Rohringer, H and Rohringer, C and Schöfbeck, R and Strauss, J and Szoncsó, F and Taurok, A and Waltenberger, W and Walzel, G and Widl, E and Wulz, C.-E and Chekhovsky, V and Emeliantchik, I and Litomin, A and Makarenko, V and Mossolov, V and Shumeiko, N and Solin, A and Stefanovitch, R and Suarez Gonzalez, J and Fedorov, A and Korzhik, M and Missevitch, O and Zuyeuski, R and Bansal, M and Bansal, S and Beaumont, W and Cornelis, T and De Wolf, E.A and Druzhkin, D and Janssen, X and Luyckx, S and Mucibello, L and Ochesanu, S and Roland, B and Roland, C and Roland, G and Rougny, R and Selvaggi, G and Selvaggi, M and Staykova, Z and Van Haevermaet, H and Van Mechelen, P and Van Remortel, N and Van Spilbeeck, A and Blekman, F and Blyweert, S and DʼHondt, J and Devroede, O and Gonzalez Suarez, R and Goorens, R and Kalogeropoulos, A and Maes, M and Olbrechts, A and Tavernier, S and Van Doninck, W and Van Lancker, L and Van Mulders, P and Van Onsem, G.P and Villella, I and Clerbaux, B and De Lentdecker, G and Dero, V and Dewulf, J.P and Gay, A.P.R and Hreus, T and Léonard, A and Marage, P.E and Mohammadi, A and Reis, T and Rugovac, S and Thomas, S and Thomas, M and ... and CMS Collaboration and Los Alamos National Lab. (LANL), Los Alamos, NM (United States) and Argonne National Lab. (ANL), Argonne, IL (United States) and Fermi National Accelerator Lab. (FNAL), Batavia, IL (United States) and Lawrence Livermore National Lab. (LLNL), Livermore, CA (United States)
Physics Letters B, ISSN 0370-2693, 09/2012, Volume 716, Issue 1, pp. 30 - 61
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2017, Volume 35, Issue 20, pp. 2260 - 2267
Journal Article